Blog
Innovative Industrial Properties Boosts Size of New Stock Issue by 48%
A unique business in the realm of marijuana stocks, Innovative Industrial Properties (NYSE: IIPR) has priced its upcoming share issue, and expanded it at the same time.
One day after announcing that
Equity Bancshares, Inc. (EQBK) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Equity Bancshares, Inc. (NASDAQ: EQBK)Q4 2019 Earnings CallJan 24, 2020, 10:00 a.m. ET
Operator
Source Fool.com
Western Alliance Bancorp (WAL) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Western Alliance Bancorp (NYSE: WAL)Q4 2019 Earnings CallJan 24, 2020, 12:00 p.m. ET
Operator
Source Fool.com
Covenant Transportation Group Inc (CVTI) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Covenant Transportation Group Inc (NASDAQ: CVTI)Q4 2019 Earnings CallJan 24, 2020, 11:00 a.m. ET
Operator
Source Fool.com
Moog Inc. (MOG.A) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool.
Moog Inc. (NYSE: MOG.A)Q1 2020 Earnings CallJan 24, 2020, 10:00 a.m. ET
Operator
Source Fool.com
Glacier Bancorp Inc (GBCI) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Glacier Bancorp Inc (NASDAQ: GBCI)Q4 2019 Earnings CallJan 24, 2020, 11:00 a.m. ET
Operator
Source Fool.com
Here's Why Synchrony Financial is Plunging Despite Strong Earnings
Synchrony Financial (NYSE: SYF), a leading issuer of store credit cards and high-yield savings accounts, released its fourth-quarter and year-end 2019 results on Friday morning, and it appears the
5 Unexpected Expenses That Could Derail Your Retirement
Disaster-proofing your budget is important at any age, but this is particularly true for retirees, who are typically living on a fixed income. All it takes is one major life-shattering event to
Roche's Tecentriq Fails to Help Patients in Muscle-Invasive Bladder Cancer Trial
Swiss pharmaceutical giant Roche (OTC: RHHBY) announced today that its cancer-immunology drug, Tecentriq, flopped in a late-stage trial evaluating patients with muscle-invasive, bladder (also known
Tencent’s CEO Sells $260 Million in Shares, but I’m Not Worried
Tencent's (OTC: TCEHY) stock recently dipped after founder and CEO Pony Ma sold five million shares to raise about HK$2 billion ($257 million) over four consecutive days. The sale reduced Ma's stake
Why Airline Stocks Are Declining Today
Concerns about the coronavirus outbreak in China weighed on airline stocks on Friday, with shares of American Airlines Group (NASDAQ: AAL) and United Holdings (NASDAQ: UAL) each trading down more
Why iQiyi Stock Dropped Today
Shares of Chinese video-streaming platform iQiyi (NASDAQ: IQ) were down 9% as of 1 p.m. EST Friday despite a lack of company-specific news. Rather, it seems today's drop is part of a broader
American Express Co (AXP) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
American Express Co (NYSE: AXP)Q4 2019 Earnings CallJan 24, 2020, 8:30 a.m. ET
Operator
Source Fool.com
Synovus Financial Corp (SNV) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Synovus Financial Corp (NYSE: SNV)Q4 2019 Earnings CallJan 24, 2020, 8:30 a.m. ET
Operator
Source Fool.com
Banner Corp (BANR) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Banner Corp (NASDAQ: BANR)Q4 2019 Earnings CallJan 24, 2020, 11:00 a.m. ET
Operator
Source Fool.com
NextEra Energy Inc (NEE) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
NextEra Energy Inc (NYSE: NEE)Q4 2019 Earnings CallJan 24, 2020, 9:00 a.m. ET
Operator
Source Fool.com
Abbot's Brain Stimulation System Approved to Treat Parkinson's
Abbott Laboratories (NYSE: ABT) announced on Friday that it's Infinity Deep Brain Stimulation (DPS) system had received approval from the Food and Drug Administration (FDA) to target specific areas
Abbott's Brain Stimulation System Approved to Treat Parkinson's
Abbott Laboratories (NYSE: ABT) announced on Friday that it's Infinity Deep Brain Stimulation (DPS) system had received approval from the Food and Drug Administration (FDA) to target specific areas
Here's Why Epizyme Is Down on Good News Today
Shares of Epizyme (NASDAQ: EPZM) are down 14.7% at 1:59 p.m. EST after the biotech gained Food and Drug Administration approval for Tazverik in patients with epithelioid sarcoma.
You read that
MidWestOne Financial Group Inc (MOFG) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
MidWestOne Financial Group Inc (NASDAQ: MOFG)Q4 2019 Earnings CallJan 24, 2020, 12:00 p.m. ET
Operator
Source Fool.com
Why Hill-Rom Holdings' Q1 Results Were Better Than They Appear at First Glance
Hill-Rom Holdings (NYSE: HRC) delivered tremendous gains for investors last year, with the medical technology stock soaring 28%. And it achieved this performance without posting splashy revenue and
An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences
Last year, Bristol-Myers Squibb (NYSE: BMY) spent $74 billion for Celgene and its mixed bag of commercial and clinical-stage drugs. Analysts are still arguing about whether the big pharma overpaid
National Bank Holdings Corporation (NBHC) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
National Bank Holdings Corporation (NYSE: NBHC)Q4 2019 Earnings CallJan 24, 2020, 11:00 a.m. ET
Operator
Source Fool.com
Seacoast Banking Corp of Florida (SBCF) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Seacoast Banking Corp of Florida (NASDAQ: SBCF)Q4 2019 Earnings CallJan 24, 2020, 10:00 a.m. ET
Operator
Source Fool.com
Ameris Bancorp (ABCB) Q4 2019 Earnings Call Transcript
Image source: The Motley Fool.
Ameris Bancorp (NASDAQ: ABCB)Q4 2019 Earnings CallJan 24, 2020, 9:30 a.m. ET
Operator
Source Fool.com